Julian R Molina Selected Research

PFK158

10/2022	PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.
1/2022	PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
1/2019	PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julian R Molina Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 07/2003
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 07/2003
13	Lung Neoplasms (Lung Cancer) 01/2019 - 04/2003
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 06/2006
6	Fatigue 07/2019 - 10/2007
5	Adenocarcinoma 01/2020 - 04/2005
5	Carcinogenesis 01/2019 - 11/2005
4	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2010
4	Mesothelioma 01/2020 - 07/2003
4	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2005
4	Nausea 03/2016 - 10/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 07/2003
3	Malignant Mesothelioma 01/2020 - 08/2016
3	Breast Neoplasms (Breast Cancer) 03/2016 - 01/2005
3	Disease Progression 08/2014 - 10/2010
3	Diarrhea 05/2014 - 05/2007
3	Carcinoma (Carcinomatosis) 10/2013 - 05/2008
3	Anaplastic Thyroid Carcinoma 09/2012 - 10/2010
2	Carcinoid Tumor (Carcinoid) 01/2020 - 10/2018
2	Vomiting 03/2016 - 01/2015
2	Hyperglycemia 01/2015 - 10/2007
2	Hypertension (High Blood Pressure) 05/2014 - 09/2012
2	Oropharyngeal Neoplasms 04/2014 - 11/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2013 - 05/2008
2	Barrett Esophagus (Barrett's Esophagus) 09/2005 - 04/2005
1	Tics (Tic) 10/2022
1	Adenocarcinoma of Lung 02/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Multiple Myeloma 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 11/2020
1	Neuroendocrine Carcinoma 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Empyema 01/2020
1	Atrial Fibrillation 01/2020
1	Anemia 07/2019
1	Measles 01/2019

Drug/Important Bio-Agent (IBA)

8	ErbB Receptors (EGF Receptor)IBA 02/2021 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 11/2020 - 09/2005
7	Pharmaceutical PreparationsIBA 01/2019 - 07/2008
6	Phosphotransferases (Kinase)IBA 12/2020 - 10/2010
5	Immune Checkpoint InhibitorsIBA 12/2021 - 07/2019
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2005
5	pazopanib FDA Link 01/2020 - 10/2010
5	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 10/2005
4	Pemetrexed (MTA)FDA Link 08/2014 - 07/2003
3	PFK158IBA 10/2022 - 01/2019
3	Programmed Cell Death 1 ReceptorIBA 12/2021 - 11/2020
3	Gemcitabine FDA Link 01/2020 - 07/2008
3	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 10/2005
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 05/2008
3	PlatinumIBA 01/2020 - 08/2014
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2008
3	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 04/2003
3	Bevacizumab (Avastin)FDA Link 08/2014 - 05/2008
3	Messenger RNA (mRNA)IBA 11/2012 - 04/2005
3	Sorafenib (BAY 43-9006)FDA Link 12/2010 - 05/2007
3	Topotecan (Hycamtin)FDA LinkGeneric 10/2010 - 06/2006
2	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2008
2	Everolimus FDA Link 12/2020 - 01/2020
2	LigandsIBA 11/2020 - 07/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2019 - 10/2007
2	Hormones (Hormone)IBA 01/2018 - 03/2016
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2005
2	CrizotinibIBA 01/2016 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 04/2014
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 07/2012
2	Decitabine FDA Link 07/2015 - 04/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2015 - 10/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 06/2006
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2012 - 05/2008
2	Monoclonal AntibodiesIBA 10/2007 - 10/2006
2	hydrogen sulfite (bisulfite)IBA 02/2006 - 04/2005
1	EnzymesIBA 01/2022
1	B7-H1 AntigenIBA 12/2021
1	selinexorIBA 01/2021
1	SalicylatesIBA 01/2021
1	choline salicylateIBA 01/2021
1	vatalanib (PTK787)IBA 12/2020
1	Apoptosis Regulatory ProteinsIBA 11/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	HhAntag691IBA 01/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020
1	Thyroglobulin FDA Link 01/2020
1	IodineIBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	VaccinesIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	FructoseIBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019

Therapy/Procedure

31	Therapeutics 12/2021 - 07/2003
16	Drug Therapy (Chemotherapy) 01/2020 - 07/2004
5	Radiotherapy 01/2020 - 05/2008
4	Immunotherapy 09/2021 - 01/2020
2	Drug Tapering 09/2012 - 10/2010
1	Salvage Therapy 01/2020
1	Debridement 01/2020
1	Tracheostomy 01/2020